Taysha Gene Therapies Announcement

Taysha Gene Therapies have announced today that their clinical trial of TSHA 102 which is taking place in Canada, has now been expanded to include patients with Rett syndrome age 12 and over.

This is good news for the Canadian Rett community and speaks to the company’s commitment to try to bring this treatment to patients with Rett of all ages.

You can read the full press release here